To view this email as a web page, click here.

Percentage of Patients to Benefit From Immune Checkpoint Inhibitors Still Limited

The percentage of patients with cancer eligible to receive immune checkpoint inhibitors has increased in recent years, but how many patients are actually responding?

New Findings on Continuous vs Intermittent Chemotherapy in Advanced Breast Cancer

Researchers discussed new findings on continuous vs intermittent chemotherapy schedules in advanced breast cancer at the ESMO Breast Cancer Congress.

IN CASE YOU MISSED IT

Potential Role of the HPV Vaccine in Preventing Non-Melanoma Skin Cancers

The association between the presence of several viruses and non-melanoma skin cancer was investigated in a recent study.

Read more

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.